Animal Biosafety Level 3 Telemetry Infrastructure
动物生物安全 3 级遥测基础设施
基本信息
- 批准号:10192114
- 负责人:
- 金额:$ 50万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AgingAnesthesia proceduresAnestheticsAnimalsAreaAssisted Reproductive TechnologyBehavioralBioinformaticsBiomedical ResearchBiometryBlood PressureBusinessesCOVID-19 pandemicCardiacClinical MedicineCommunicable DiseasesCommunitiesDataDevelopmentDevicesEndocrineEnvironmentExposure toFlow CytometryFundingGeneticGoalsGrantHealthHealth SciencesHealth Services ResearchHumanImmunologyImplantInfectious AgentInfectious Diseases ResearchInformation SystemsInfrastructureInstitutionJapanese MonkeyLibrariesLogisticsMagnetic Resonance ImagingMeasuresMentorsModelingModernizationMolecularMolecular VirologyNeurosciencesObesityOregonPathologyPhysiologicalPre-Clinical ModelPreventionPrimatesRequest for ApplicationsResearchResearch PersonnelResearch SupportResourcesRiskSafetyScienceServicesSystemTechnologyTelemetryTemperatureTherapeuticTrainingTraining and EducationTranslational ResearchUnited States National Institutes of HealthUniversitiesanimal careanimal databasebiosafety level 3 facilitycardiometabolismdesignhigh riskhigh standardhuman diseaseimprovedinfrastructure developmentmodel developmentnext generationnonhuman primateoperationoutreachpandemic diseaseprogramsreproductiverespiratorystemsurgical servicesystems researchvaccine development
项目摘要
PROJECT SUMMARY
The Oregon National Primate Research Center (ONPRC), located on the West Campus of Oregon Health &
Science University (OHSU), requests funds to renew grant P51--OD011092 for the next five--year period (May
1, 2019--April 30, 2024). Currently in its 59th year of operation, the ONPRC has served a broad range of local,
regional, and national investigators performing biomedical research in nonhuman primate (NHP) models with
the goal of improving human health. The goals for the next funding period are reflected in the following Specific
Aims: 1) Conduct state--of--the--art research that advances understanding of causes and the development of
preventions, treatments, and cures for debilitating human diseases; 2) Provide exceptional NHP expertise and
services to researchers at the local, regional, and national levels to advance NIH-- and other federally--
supported research programs; 3) Pursue the highest standards of humane and responsible animal care; and 4)
Mentor and train the next generation of translational NHP researchers and educate the public about the
importance of biomedical research. To accomplish these aims, support is requested in seven broad areas.
These areas are: (1) Administration, which provides the administrative and service support required for all
aspects of the ONPRC (Governance, Director's Office, Business Services, Facilities, Improvements and
Modernization, Information Systems, Research Library, and Research Safety); (2) Animal Services [Resources
& Logistics, Operations, Pathology Services, Surgical Services, Behavioral Services, Education and Training,
Clinical Medicine, and NHP Resources (Obese, Aging, Infectious Disease, and Japanese Macaque)] ; (3) Core
Science Services [Research Cores (Assisted Reproductive Technologies, Bioinformatics & Biostatistics,
Endocrine Technologies, Flow Cytometry, Integrated Pathology, Molecular Technologies, Molecular Virology,
Magnetic Resonance Imaging (MRI), and Primate Genetics)] ; (4) Scientific Components, including support for
Scientific Divisions (Cardiometabolic Health, Genetics, Neuroscience, Pathobiology & Immunology, and
Reproductive & Developmental Sciences); (5) Pilot Research Program; (6) Outreach and Community
Engagement; and (7) NPRC Consortium--Based Activities.
ONPRC's overarching goal is to develop, study, and share NHP models that can inform the causes of human
diseases, leading to better preventions, treatments, and cures. The ONPRC achieves this goal by supporting
translational research and expertise in models that are provided locally, regionally, and nationally on a
collaborative basis. The host institution, OHSU, recognizes the ONPRC as one of the university's `top five'
strengths and has pledged to continue support for programmatic integration and infrastructure development.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Gordon Barr-Gillespie其他文献
Peter Gordon Barr-Gillespie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Gordon Barr-Gillespie', 18)}}的其他基金
Genomic Sequencing of Aged Nonhuman Primates at ONPRC
ONPRC 对老年非人类灵长类动物进行基因组测序
- 批准号:
10662148 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Novel Therapy for SARS-CoV-2 Virus Infection and Pathogenesis by Aerosol Delivery of Monoclonal Antibodies
通过单克隆抗体气溶胶递送治疗 SARS-CoV-2 病毒感染和发病机制的新疗法
- 批准号:
10400511 - 财政年份:2021
- 资助金额:
$ 50万 - 项目类别:
Nanoliter-scale Affinity Purification Mass Spectrometry for Small Numbers of Hair Cells
少量毛细胞的纳升级亲和纯化质谱分析
- 批准号:
10472639 - 财政年份:2021
- 资助金额:
$ 50万 - 项目类别:
Nanoliter-scale Affinity Purification Mass Spectrometry for Small Numbers of Hair Cells
少量毛细胞的纳升级亲和纯化质谱分析
- 批准号:
10284899 - 财政年份:2021
- 资助金额:
$ 50万 - 项目类别:
Functions of Myosin VII in Mechanosensory Hair Cells
肌球蛋白 VII 在机械感觉毛细胞中的功能
- 批准号:
9027704 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Functions of Myosin VII in Mechanosensory Hair Cells
肌球蛋白 VII 在机械感觉毛细胞中的功能
- 批准号:
9177753 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
IDENT OF DEAFNESS-CAUSING MUTATIONS USING PROTEOMICS-IDENTIFIED CANDIDATES
使用蛋白质组学鉴定的候选物鉴定导致耳聋的突变
- 批准号:
8365481 - 财政年份:2011
- 资助金额:
$ 50万 - 项目类别:














{{item.name}}会员




